End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.4 CNY | +1.79% |
|
-2.15% | -19.32% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-19.32% | 790M | - | ||
-3.33% | 37.38B | B- | ||
-29.46% | 19.13B | B- | ||
-27.78% | 11.43B | B- | ||
+2.73% | 11.01B | A- | ||
-19.58% | 9.21B | B+ | ||
+26.96% | 8.96B | C+ | ||
-10.94% | 5.51B | C+ | ||
-41.24% | 4.35B | C | ||
-23.89% | 3.53B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 301216 Stock
- Ratings Wankai New Materials Co., Ltd.